Core Laboratories N.V.CLBNYSE

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

33 analysts·High coverage

48%

Rating Distribution

Strong Buy

00%

Buy

1648%

Hold

1442%

Sell

39%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 28% higher.

Bear Case

$17.00

-13%

Consensus

$25.00

+28%

Bull Case

$32.00

+64%

Price Range33 analysts

Low

Consensus

High

$17.00

$32.00

Current Target

Current Price

$19.54

Upside to Target

$5.46

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.81(2 analysts)

P/E29x

Current: 28.6x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+3.83%

EPS+18.73%

FY2028

Rev+15.40%

EPS+54.70%

Earnings Surprises

Beat rate:67%(8/12 quarters)

Avg surprise:+5.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jul 15, 2024Piper Sandler

Core Laboratories price target lowered to $17 from $18 at Piper Sandler

Target:$17.00

-21.9%from $21.78

Feb 7, 2023Citigroup

Citigroup Maintains Neutral on Core Laboratories, Raises Price Target to $26

Target:$26.00

-0.8%from $26.20

May 2, 2022Morgan Stanley

Morgan Stanley Maintains Equal-Weight on Core Laboratories, Lowers Price Target to $32

Target:$32.00

+20.1%from $26.65

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance